Translator Disclaimer
27 October 1995 Physician access to drug profiles to reduce adverse reactions
Author Affiliations +
Proceedings Volume 2499, Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions; (1995) https://doi.org/10.1117/12.225311
Event: Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions, 1995, Arlington, VA, United States
Abstract
Adverse drug reactions (ADRs) are a major source of preventable morbidity and mortality, especially among the elderly, who use more drugs and are more sensitive to them. The insurance industry has recently addressed this problem through the implementation of drug interaction alerts to pharmacists in conjunction with immediate online claims adjudication for almost 60% of prescriptions (expected to reach 90% within 5 years). These alerts are based on stored patient drug profiles maintained by pharmacy benefit managers (PBMs) which are updated whenever prescriptions are filled. While these alerts are very helpful, the pharmacist does not prescribe, resulting in time-consuming and costly delays to contact the physician and remedy potential interactions. We have developed and demonstrated the feasibility of the PINPOINT (Pharmaceutical Information Network for prevention of interactions) system for making the drug profile and interaction information easily available to the physician before the prescription is written. We plan to test the cost-effectiveness of the system in a prospective controlled clinical trial.
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
William A. Yasnoff, Edward L. Tomkins, and Louise M. Dunn "Physician access to drug profiles to reduce adverse reactions", Proc. SPIE 2499, Health Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions, (27 October 1995); https://doi.org/10.1117/12.225311
PROCEEDINGS
10 PAGES


SHARE
Advertisement
Advertisement
RELATED CONTENT


Back to Top